Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Masashi Kondo
Fujita Health University
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
50
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Efficacy of pembrolizumab plus pemetrexed in older patients with non-squamous NSCLC according to PD-L1 expression status: Results from the CJLSG1901 study
Number of pages: 26
Posted: 16 Sep 2025
Yoshihito Kogure
,
Masahide Mori
,
Takashi Abe
,
Akiko M. Saito
,
Nobuyuki Yamamoto
,
Hideo Saka
, Masashi Kondo,
Satoshi Ikeda
,
Toshiyuki Harada
,
Aoi Hino
,
Satoru Miura
,
Yasuhiro Goto
,
Keiichi Fujiwara
,
Nobuyuki Katakami
,
Kaoru Kubota
,
Naohiko Murata
and
Hiroya Hashimoto
National Hospital Organization Nagoya Medical Center, National Hospital Organization (NHO) - Osaka Toneyama Medical Center, Ogaki Municipal Hospital, National Hospital Organization (NHO), Nagoya Medical Center, Clinical Research Center, Wakayama Medical University - Department of Pulmonary Medicine and Medical Oncology, Matsunami General Hospital, Fujita Health University, Kanagawa Cardiovascular and Respiratory Center, Hokkaido University Hospital - Division of Laboratory and Transfusion Medicine, Chiba University,
affiliation not provided to SSRN
, Fujita Health University,
affiliation not provided to SSRN
, Takarazuka City Hospital, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital and Nagoya City University - Core Laboratory
Downloads
50
(1,063,489)
View PDF
Download
Abstract:
Pembrolizumab, Pemetrexed, non-squamous nons-mall cell lung cancer, PD-L1, older patients
Feedback